Status unknownNCT05115084Updated Nov 10, 2021

The Effect of the COVID-19 Epidemic Process on the Nutritional Habits and Body Weights of Adults

An observational study in COVID-19 Pandemic, Eating Habit and Weight Gain, sponsored by Istanbul Medeniyet University. Status unknown. Open to participants aged 19 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-10.

Sponsored by Istanbul Medeniyet University · Observational

The sponsor has not verified this record recently (last verified Nov 2021), so the status shown — last known as Not yet recruiting — may be out of date.

Study type: Observational
Model: Case-only
Time perspective: Prospective
Enrollment: 160
Ages: 19 Years to 70 Years
Sex: All

Study summary

During the COVID-19 epidemic, the time spent by adults on the stomach has increased. Therefore, the likelihood of adverse changes in lifestyles has increased. In this study, the changes in nutritional habits, physical activities and body weights of adult individuals during the epidemic will be evaluated. A questionnaire including questions about nutritional habits, physical activity status and changes in body weights will be administered to individuals. The results will be evaluated with the appropriate statistical method. The survey will be administered once. The estimated time to reach the total number is 3 months.

Conditions studied

COVID-19 Pandemic
Eating Habit
Weight Gain

Browse trials for

In context

COVID-19

7,774 studies on the registry are indexed under COVID-19; 482 are open to participants now.

This study's planned enrollment of 160 is below the median of 260 across 3,188 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

Istanbul Medeniyet University is the lead sponsor of 191 studies on the registry; 18 are open to participants now.

Browse Istanbul Medeniyet University studies →

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 19 Years to 70 Years
Sexes eligible: All
Accepts healthy volunteers: Yes
Sampling method: Non-probability sample

Study population

All individuals between the ages of 19 and 70 who agreed to participate in the study.

Eligibility criteria

Inclusion Criteria: Adult individuals wishing to participate in the study -

Exclusion Criteria: Individuals outside the age range of 19-70 years, all individuals who did not agree to participate in the study.

Study design

Observational model: Case-only
Time perspective: Prospective
Enrollment: 160 participants (estimated)
Patient registry: No

Interventions

Otherno intervention
no intervention

What researchers measure

Primary outcomes

Questionnaire
A questionnaire containing a total of 45 questions will be applied, of which 10 are for demographic information, 31 for determining changes in body weight and eating habits, and 4 for physical activity.
Time frame: 12 weeks

Study locations

No study locations are listed for this record.

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2021; primary completion for Jan 2022, 1 month later.

Of 1,625 non-industry observational studies under COVID-19, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 29. This study's planned 1 month is below that.

Counting every sponsor, half of 1,750 studies reached it within 13 months; a quarter within 5 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered: Nov 6, 2021
First posted: Nov 10, 2021
StartEst.: Dec 3, 2021
Primary completionEst.: Jan 31, 2022
CompletionEst.: Jun 2, 2022
Last update: Nov 10, 2021

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Nov 10, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT05115084
Lead sponsor: Istanbul Medeniyet University
Responsible party: Gülin Öztürk Özkan (Associate professor, Istanbul Medeniyet University) — Principal investigator
First posted: Nov 10, 2021
Start date: Dec 3, 2021 (estimated)
Primary completion: Jan 31, 2022 (estimated)
Completion: Jun 2, 2022 (estimated)
Last update: Nov 10, 2021

Oversight

FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

COVID-19 →

Other studies from this sponsor

Istanbul Medeniyet University →

Start the discussion